Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Sodium 3(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate was tested for acute toxicity by oral and dermal application to the rat according to OECD guideline 401 and 402. The LD50 (oral) was greater than 5000 mg/kg bw and the LD50 (dermal) was greater than 2000 mg/kg bw.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Dose descriptor:
LD50
Value:
5 000 mg/kg bw

Acute toxicity: via dermal route

Endpoint conclusion
Dose descriptor:
LD50
Value:
2 000 mg/kg bw

Additional information

Acute toxicity oral:

The test article sodium 3(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate was administered to rats of both sexes by oral gavage, at a dose of 5000 mg/kg according to OECD giudeline 401.

The following death rate was observed: 10 % at 5000 mg/kg.

The acute oral LD50 of test item in 10 rats (5 males/5 females) of both sexes, observed over a period of 15 days, was estimated to be greater than 5000 mg/kg.

Acute toxicity dermal:

The test article sodium 3(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate was applied to the skin of rats of both sexes by oral gavage for 24 hours at a dose of 2000 mg/kg according to OECD giudeline 402.

The following death rate was observed: 0 % at 2000 mg/kg.

Therefore, the LD50 of test item was estimated to be greater than 2000 mg/kg.

Justification for classification or non-classification

Based on all available information, the test substance is not classified with regard to acute toxicity according to Directive 67/548/EEC (DSD) and to Regulation (EC) No 1272/2008 (CLP), respectively.